|
Marknaden stängd -
Andra börsplatser
|
Efter stängning 20.09.54 | |||
| 9,646 EUR | +1,92 % |
|
9,649 | +0,03 % |
| 04-16 | Grifols erhåller FDA-godkännande för screeningtest av malaria i blod | RE |
| 04-15 | Europeiska ADR-noteringar backar i den amerikanska handeln på onsdagen | MT |
| Skatteperiod: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Lönsamhet | ||||||||||
Return on Assets | 2,04 | 2,13 | 2,14 | 3,89 | 4,24 | |||||
Return on Total Capital | 2,26 | 2,37 | 2,43 | 4,42 | 4,84 | |||||
Return On Equity % | 3,57 | 3,44 | 2,2 | 2,64 | 6,17 | |||||
Return on Common Equity | 3,26 | 3,57 | 0,99 | 2,79 | 7,21 | |||||
Marginalanalys | ||||||||||
Gross Profit Margin % | 39,78 | 36,8 | 37,84 | 39,48 | 38,8 | |||||
SG&A Margin | 21,52 | 19,63 | 20,73 | 16,16 | 15,22 | |||||
EBITDA Margin % | 15,92 | 15,89 | 15,65 | 22,3 | 22,56 | |||||
EBITA Margin % | 12,42 | 12,53 | 12,38 | 19,22 | 19,37 | |||||
EBIT Margin % | 11,4 | 11,46 | 11,16 | 18,3 | 18,54 | |||||
Income From Continuing Operations Margin % | 5,38 | 4,47 | 2,74 | 2,95 | 6,65 | |||||
Net Income Margin % | 3,71 | 3,43 | 0,9 | 2,18 | 5,34 | |||||
Net Avail. For Common Margin % | 3,71 | 3,43 | 0,9 | 2,18 | 5,34 | |||||
Normalized Net Income Margin | 2,77 | 2,61 | 0,52 | 4,5 | 5 | |||||
Levered Free Cash Flow Margin | 1,32 | −15,25 | −19,12 | 20,16 | 13,62 | |||||
Unlevered Free Cash Flow Margin | 4,28 | −11,51 | −14,92 | 25,38 | 18,41 | |||||
Tillgångsomslutning | ||||||||||
Asset Turnover | 0,29 | 0,3 | 0,31 | 0,34 | 0,37 | |||||
Fixed Assets Turnover | 1,55 | 1,61 | 1,58 | 1,7 | 1,8 | |||||
Receivables Turnover (Average Receivables) | 12,07 | 11,25 | 9,86 | 10,06 | 10,2 | |||||
Inventory Turnover (Average Inventory) | 1,39 | 1,4 | 1,23 | 1,24 | 1,34 | |||||
Kortfristig likviditet | ||||||||||
Current Ratio | 1,59 | 2,38 | 2,79 | 2,66 | 2,51 | |||||
Quick Ratio | 0,92 | 0,68 | 0,63 | 0,87 | 0,84 | |||||
Operating Cash Flow to Current Liabilities | 0,17 | −0,01 | 0,09 | 0,42 | 0,52 | |||||
Days Sales Outstanding (Average Receivables) | 30,24 | 32,44 | 37,01 | 36,39 | 35,78 | |||||
Days Outstanding Inventory (Average Inventory) | 261,82 | 260,04 | 296,67 | 295,27 | 271,73 | |||||
Average Days Payable Outstanding | 69,58 | 52,02 | 64,74 | 69,01 | 71,18 | |||||
Cash Conversion Cycle (Average Days) | 222,48 | 240,46 | 268,93 | 262,66 | 236,32 | |||||
Långsiktig solvens | ||||||||||
Total Debt/Equity | 114,57 | 127,11 | 133,58 | 118,12 | 126,83 | |||||
Total Debt / Total Capital | 53,39 | 55,97 | 57,19 | 54,15 | 55,91 | |||||
LT Debt/Equity | 85,17 | 117,71 | 120,87 | 110,27 | 119,57 | |||||
Long-Term Debt / Total Capital | 39,69 | 51,83 | 51,75 | 50,55 | 52,71 | |||||
Total Liabilities / Total Assets | 57,64 | 60,72 | 62,82 | 59,79 | 61,43 | |||||
EBIT / Interest Expense | 2,41 | 1,92 | 1,66 | 2,19 | 2,42 | |||||
EBITDA / Interest Expense | 3,64 | 2,88 | 2,51 | 2,81 | 3,09 | |||||
(EBITDA - Capex) / Interest Expense | 2,59 | 2,14 | 2,04 | 2,42 | 2,63 | |||||
Total Debt / EBITDA | 10,95 | 10,3 | 9,59 | 6,01 | 5,42 | |||||
Net Debt / EBITDA | 7,8 | 9,74 | 9,01 | 5,42 | 4,94 | |||||
Total Debt / (EBITDA - Capex) | 15,43 | 13,83 | 11,82 | 6,97 | 6,37 | |||||
Net Debt / (EBITDA - Capex) | 10,99 | 13,08 | 11,1 | 6,29 | 5,81 | |||||
Tillväxt jämfört med föregående år | ||||||||||
Total Revenues, 1 Yr. Growth % | −7,62 | 22,92 | 8,71 | 9,41 | 4,33 | |||||
Gross Profit, 1 Yr. Growth % | −12,97 | 13,7 | 11,79 | 11,69 | 2,53 | |||||
EBITDA, 1 Yr. Growth % | −34,06 | 22,66 | 7,11 | 27,45 | 5,59 | |||||
EBITA, 1 Yr. Growth % | −40,41 | 24,01 | 7,37 | 33,13 | 5,19 | |||||
EBIT, 1 Yr. Growth % | −42,33 | 23,49 | 5,9 | 37,3 | 5,75 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | −62,58 | 2,19 | −33,37 | 30,02 | 134,74 | |||||
Net Income, 1 Yr. Growth % | −70,45 | 10,36 | −71,52 | 270,81 | 156,05 | |||||
Normalized Net Income, 1 Yr. Growth % | −70,24 | 11,07 | −79,79 | 103,21 | 16,14 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | −70,2 | 10,64 | −71,52 | 283,33 | 156,52 | |||||
Accounts Receivable, 1 Yr. Growth % | 13,28 | 48,3 | 7,61 | 7,01 | −0,94 | |||||
Inventory, 1 Yr. Growth % | 12,84 | 41,69 | 8,06 | 2,23 | −7,42 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11,33 | 24,69 | 0,57 | 2,81 | −5,99 | |||||
Total Assets, 1 Yr. Growth % | 25,92 | 11,96 | −0,43 | 1,97 | −7,91 | |||||
Tangible Book Value, 1 Yr. Growth % | −5,81 | 29,23 | −1,18 | 2,56 | −5,2 | |||||
Common Equity, 1 Yr. Growth % | 19,35 | 10,98 | −4,94 | 9,6 | −10,4 | |||||
Cash From Operations, 1 Yr. Growth % | −46,23 | −101,82 | −2,02 tn | 312,53 | 16,08 | |||||
Capital Expenditures, 1 Yr. Growth % | −11,7 | 7,73 | −21,37 | 3,61 | 13,73 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | −90,91 | −1,6 tn | 36,28 | −186,69 | −29,48 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | −75,26 | −436,28 | 40,91 | −235,1 | −24,3 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Sammansatt Årlig Tillväxthastighet Över Två År | ||||||||||
Total Revenues, 2 Yr. CAGR % | −1,64 | 6,56 | 15,6 | 9,06 | 6,84 | |||||
Gross Profit, 2 Yr. CAGR % | −8,44 | −0,53 | 12,74 | 13,42 | 8,43 | |||||
EBITDA, 2 Yr. CAGR % | −25,75 | −13,81 | 5,78 | 21,9 | 20,75 | |||||
EBITA, 2 Yr. CAGR % | −26,12 | −11,74 | 20,43 | 43,69 | 42,46 | |||||
EBIT, 2 Yr. CAGR % | −29,21 | −15,61 | 14,36 | 40,19 | 39,4 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | −36,04 | −38,16 | −17,48 | −7,35 | 75,14 | |||||
Net Income, 2 Yr. CAGR % | −45,92 | −41,97 | −43,94 | −7,91 | 209,38 | |||||
Normalized Net Income, 2 Yr. CAGR % | −48,3 | −41,27 | −52,01 | 50,24 | 597,02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | −45,71 | −41,65 | −43,86 | −7,7 | 213,58 | |||||
Accounts Receivable, 2 Yr. CAGR % | 8,35 | 29,62 | 26,33 | 7,28 | 2,93 | |||||
Inventory, 2 Yr. CAGR % | −1,79 | 26,45 | 23,74 | 4,89 | −2,71 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8,05 | 17,82 | 11,98 | 0,3 | −1,69 | |||||
Total Assets, 2 Yr. CAGR % | 11,24 | 18,73 | 5,58 | 0,41 | −3,1 | |||||
Tangible Book Value, 2 Yr. CAGR % | −20,26 | 35,32 | 13,01 | 0,35 | −1,38 | |||||
Common Equity, 2 Yr. CAGR % | 12,44 | 9,54 | 2,71 | 2,06 | −0,91 | |||||
Cash From Operations, 2 Yr. CAGR % | 2,43 | −90,11 | −40,93 | 2,41 tn | 119,66 | |||||
Capital Expenditures, 2 Yr. CAGR % | −10,73 | −2,47 | −7,96 | −9,48 | 8,77 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 318,61 | 13,82 | 352,8 | 182,56 | −25,15 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 2,97 | −9,54 | 117,68 | 337,45 | −4,14 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | - | |||||
Treårig Sammansatt Årlig Tillväxthastighet | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3,21 | 5,95 | 7,27 | 13,5 | 7,46 | |||||
Gross Profit, 3 Yr. CAGR % | −1,43 | −1,59 | 3,42 | 13,21 | 9,66 | |||||
EBITDA, 3 Yr. CAGR % | −13,72 | −12,23 | −7,33 | 20,36 | 16,18 | |||||
EBITA, 3 Yr. CAGR % | −14,9 | −12,2 | −5,78 | 35,07 | 29,47 | |||||
EBIT, 3 Yr. CAGR % | −17,29 | −14,78 | −8,97 | 32,87 | 27,61 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | −23,58 | −25,23 | −36,6 | −7,09 | 26,35 | |||||
Net Income, 3 Yr. CAGR % | −32,58 | −30,68 | −54,23 | −5,97 | 29,52 | |||||
Normalized Net Income, 3 Yr. CAGR % | −32,15 | −32,34 | −57,88 | 29,63 | 37,87 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | −32,45 | −30,43 | −54,06 | −6 | 29,77 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17,27 | 20,3 | 21,82 | 19,53 | 4,44 | |||||
Inventory, 3 Yr. CAGR % | 5,04 | 10,97 | 19,99 | 16,37 | 0,61 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 19,64 | 13,34 | 11,77 | 8,84 | −1,84 | |||||
Total Assets, 3 Yr. CAGR % | 15,52 | 11,48 | 11,97 | 3,63 | −2,44 | |||||
Tangible Book Value, 3 Yr. CAGR % | −18,29 | 7,32 | 21,86 | 16,6 | −1,52 | |||||
Common Equity, 3 Yr. CAGR % | 13 | 8,33 | 4,49 | 2,13 | −2,28 | |||||
Cash From Operations, 3 Yr. CAGR % | −6,8 | −73,27 | −42,76 | 14,76 | 801,93 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2,16 | −4,96 | −9,23 | −2,04 | −2,26 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | −21 | 529,77 | 20,87 | 187,08 | 77,86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | −11,36 | 51,94 | 4,86 | 106,6 | 143,72 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Sammansatt Årlig Tillväxthastighet Över Fem År | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4,02 | 7,03 | 8 | 7,18 | 7,1 | |||||
Gross Profit, 5 Yr. CAGR % | 0,52 | 0,73 | 4,01 | 3,99 | 5,3 | |||||
EBITDA, 5 Yr. CAGR % | −7,2 | −5,56 | −3,34 | 2,45 | 5,53 | |||||
EBITA, 5 Yr. CAGR % | −8,19 | −6,57 | −3,88 | 4,31 | 8,36 | |||||
EBIT, 5 Yr. CAGR % | −9,75 | −8,23 | −5,84 | 3,29 | 7,42 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | −13,39 | −16,33 | −21,19 | −19,98 | −6,75 | |||||
Net Income, 5 Yr. CAGR % | −19,64 | −20,66 | −36,98 | −24,15 | −8,26 | |||||
Normalized Net Income, 5 Yr. CAGR % | −21,1 | −20,17 | −39,89 | −8,68 | −3,87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | −19,6 | −20,56 | −36,87 | −24,05 | −8,1 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0,97 | 17,6 | 20,82 | 14,93 | 13,88 | |||||
Inventory, 5 Yr. CAGR % | 6,58 | 14,46 | 12,16 | 8,73 | 10,48 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13,06 | 18,82 | 16,52 | 8,52 | 6,18 | |||||
Total Assets, 5 Yr. CAGR % | 13,68 | 14,55 | 11,44 | 6,61 | 5,23 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1,64 | 2,02 | 0,95 | 8,68 | 16,33 | |||||
Common Equity, 5 Yr. CAGR % | 10,38 | 11,05 | 6,64 | 4,06 | 0,63 | |||||
Cash From Operations, 5 Yr. CAGR % | 1,53 | −58,1 | −22,34 | 9,66 | −1,17 | |||||
Capital Expenditures, 5 Yr. CAGR % | −0,16 | 1,16 | −2,01 | −5,61 | −1,11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | −4,52 | 10,99 | 57,12 | 230,24 | 7,51 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | −1,25 | −0,19 | 26,56 | 55,86 | 10,18 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | - |
- Börsen
- Aktier
- GRF Aktie
- Finanser Grifols, S.A.
- Finansiella nyckeltal
Välj din utgåva
All finansiell information anpassad till den nationella nivån
MarketScreener is also available in this country: United States.
Switch edition















